MedPath

UNIVERSITAS SEBELAS MARET

UNIVERSITAS SEBELAS MARET logo
🇮🇩Indonesia
Ownership
Private
Established
1976-01-01
Employees
-
Market Cap
-
Website
http://www.uns.ac.id

Clinical Trials

20

Active:0
Completed:14

Trial Phases

5 Phases

Phase 1:6
Phase 2:1
Phase 3:2
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (35.3%)
Not Applicable
5 (29.4%)
Phase 4
3 (17.6%)
Phase 3
2 (11.8%)
Phase 2
1 (5.9%)

Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo

Not Applicable
Completed
Conditions
Benign Paroxysmal Positional Vertigo (Disorder)
Interventions
First Posted Date
2025-07-20
Last Posted Date
2025-07-20
Lead Sponsor
Universitas Sebelas Maret
Target Recruit Count
44
Registration Number
NCT07075289
Locations
🇮🇩

Dr. Moewardi Regional General Hospital, Surakarta, Central Java, Indonesia

Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV

Not Applicable
Not yet recruiting
Conditions
Human Immunodeficiency Virus (HIV) Infection
HIV Prevention
Adolescent Health
Digital Education Interventions
Digital Health Intervention
Health Education
HIV Stigma
First Posted Date
2025-06-26
Last Posted Date
2025-06-26
Lead Sponsor
Universitas Sebelas Maret
Target Recruit Count
400
Registration Number
NCT07039682
Locations
🇮🇩

Universitas Sebelas Maret, Surakarta, Jawa Tengah, Indonesia

The Effect of Atorvastatin 80 Mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients

Not Applicable
Completed
Conditions
STEMI (STE-ACS)
Primary PCI for STEMI
Interventions
First Posted Date
2025-03-11
Last Posted Date
2025-03-11
Lead Sponsor
Universitas Sebelas Maret
Target Recruit Count
40
Registration Number
NCT06871358
Locations
🇮🇩

RSUD Dr Moewardi, Surakarta, Jawa Tengah, Indonesia

The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis

Not Applicable
Completed
Conditions
Sepsis Newborn
Interventions
Other: Control Group
Drug: Treatment Group
First Posted Date
2024-01-05
Last Posted Date
2024-01-05
Lead Sponsor
Universitas Sebelas Maret
Target Recruit Count
42
Registration Number
NCT06191523
Locations
🇮🇩

Dwi Hidayah, Surakarta, Central Java, Indonesia

The Disease Severity In Patients With Psoriasis

Completed
Conditions
Psoriasis
First Posted Date
2023-07-13
Last Posted Date
2023-07-13
Lead Sponsor
Universitas Sebelas Maret
Target Recruit Count
33
Registration Number
NCT05943405
Locations
🇮🇩

Universitas Sebelas Maret Hospital, Sukoharjo, Central Java, Indonesia

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.